Copyright
©The Author(s) 2024.
World J Hepatol. May 27, 2024; 16(5): 766-775
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.766
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.766
Figure 1
Combined hepatocellular-cholangiocarcinoma (HE, × 15).
Figure 2 Demonstrates immunohistochemical features of combined hepatocellular-cholangiocarcinoma.
A: Hep-par1 immunostaining in hepatocellular component (× 5); B: Strong EMA immunostaining in cholangiocarcinoma component (× 3); C: Nestin immunostaining in a combined hepatocellular- cholangiocarcinoma (× 7.5).
- Citation: Vij M, Veerankutty FH, Rammohan A, Rela M. Combined hepatocellular cholangiocarcinoma: A clinicopathological update. World J Hepatol 2024; 16(5): 766-775
- URL: https://www.wjgnet.com/1948-5182/full/v16/i5/766.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i5.766